Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04852198

Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial

A Study on Safety and Efficacy Comparing 150cm One Anastomosis Gastric Bypass With 150cm Biliopancreatic Limb Roux-en-Y Gastric Bypass (Roux-en-WHY?): An Open Label, Multicentre Non-inferiority Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
298 (estimated)
Sponsor
Flevoziekenhuis · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the safety and efficiency of OAGB compared to RYGB

Detailed description

Rationale: to compare two different types of gastric bypass operations on surgical outcome. Objective: to compare two established procedures in order to find the optimal procedure in terms of weight loss and metabolic control that is associated with the fewest side-effects and complications, and decreased invasiveness. Study design: A multicentre, open label, non-inferiority randomized controlled trial Study population: Patients are eligible for inclusion if their body-mass index (BMI) was 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, osteoarthritis of the hip or knee) and a positive evaluation by our bariatric multidisciplinary team (BMDT) and are aged 18-65. Intervention: Group 1: One Anastomosis Gastric Bypass with 150cm biliopancreatic limb. Group 2: Roux-en-Y gastric bypass with biliopancreatic limb of 150cm and 75cm alimentary limb. Main study parameters/endpoints: Primary endpoint: % Excess BMI loss at two years Secondary endpoints: Metabolic status Nutritional status Comorbidity remission QOL Complications or serious adverse events (SAE's)

Conditions

Interventions

TypeNameDescription
PROCEDUREOAGBSimplified gastric bypass procedure
PROCEDURERYGBRoux-en-Y gastric bypass. Standard procedure in the Netherlands

Timeline

Start date
2021-12-13
Primary completion
2027-06-13
Completion
2029-11-01
First posted
2021-04-21
Last updated
2024-04-23

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04852198. Inclusion in this directory is not an endorsement.